2024-01-31 07:04:24 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries Limited (TEVA) Presents at J.P. Morgan 42nd Annual Global Healthcare Conference (Transcript)
- Teva: 4 Key Drivers For A 2024 Revival (Upgraded Rating)
- Teva Pharmaceutical Industries Limited (TEVA) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)
- Teva to divest API unit to focus on core business strengths
- Teva earnings preview: Israeli drugmaker to report early Wednesday
Read the full article on Seeking Alpha
For further details see:
Teva Pharmaceutical Non-GAAP EPS of $1.00 beats by $0.24, revenue of $4.46B beats by $450M